(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(p-tolyl)propanoic acid, 98%, 250mg

2-amino-1-cyclopropyl-1-phenylethanol, 95.0%, 1g

GC capillary column ROTI®Cap-5 MS, 50 m, 0.20 mm, 0.35 µm, 1 Piece(s)

4-allyl-5-[1-(3-chlorophenoxy)ethyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

(R)-Benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate, 98%, 100mg

3-(3,4-dimethoxyphenyl)pentanedioic acid, 1g

3-Pyridin-3-yl-2H-1,2,4-oxadiazol-5-one, 97%, 100mg

Methyl 2-Formylbenzoate>98.0%(GC)5g

5-Bromo-2-cyclopropylpyrimidine, 95.0%, 250mg

3,4-DIFLUORO-5-HYDROXYBENZALDEHYDE, 95.0%, 10g

(S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea, 98.0%, 10mg

trans-3-fluorocyclobutane-1-carboxylic acid, 97.0%, 250mg

4,5,6,7-Tetrahydrobenzo[c]thiophene-1-carboxylic acid, 95.0%, 250mg